Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

BUY
$113.24 - $131.95 $27 Million - $31.5 Million
238,600 Added 29.02%
1,060,700 $140 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $3.9 Million - $4.24 Million
38,900 Added 4.97%
822,100 $89.6 Million
Q2 2023

Aug 14, 2023

BUY
$108.61 - $118.38 $56.8 Million - $61.9 Million
523,200 Added 201.23%
783,200 $90.4 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $55.4 Million - $61.8 Million
-537,700 Reduced 67.41%
260,000 $27.7 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $39.9 Million - $51.2 Million
-456,400 Reduced 36.39%
797,700 $88.5 Million
Q3 2022

Nov 14, 2022

SELL
$84.53 - $94.96 $11.9 Million - $13.4 Million
-140,600 Reduced 10.08%
1,254,100 $108 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $328B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.